Center for Cancer and Blood Disorders, PC

Fort Worth, Texas 76104

0 studies enrolling now · 3 studies all time

What they study most

Colorectal Cancer, Indolent Non-Hodgkin's Lymphomas, Pancreatic Cancer

Studies at this site

• Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma — Stopped early
• Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas — Stopped early
• A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma — Completed